241
Views
0
CrossRef citations to date
0
Altmetric
Review

Otitis Media: Immediate Antibiotics or Watchful Waiting?

Pages 107-122 | Published online: 16 Oct 2007
 

Abstract

Immediate antibiotic treatment for children with acute otitis media (AOM) has been shown to improve symptoms, although failure, relapse and recurrence are common following antibiotic treatment. Until recently, almost all children in the USA received antibiotics for the immediate management of AOM. However, widespread use of antibiotics for AOM has led to the emergence of multidrug-resistant bacteria. Studies indicate that antibiotic prescribing for AOM can be reduced in children with nonsevere AOM by as much as 50% without serious harmful consequences, because symptoms can be effectively controlled in such children with analgesic medication alone. Substantial data now exist, and guidelines support, the use of watchful waiting or a wait-and-see prescription for selected children with AOM. This paper will summarize the reasons why watchful waiting may be an appropriate alternative treatment for selected children with AOM. We will also describe a simple screening method that can facilitate clinical decision making.

Financial & competing interests disclosure

Financial support was provided in part by the General Clinical Research Center at UTMB, Grant M01 RR 00073; the National Center for Research Resources, NIH, USPHS; the Agency for Healthcare Research and Quality grant R01-HS10613–02; and the clinical Research Education Program at UTMB, NIH K30-RR022276–08. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Notes

*Ear card photos 4–7 meet these criteria.

Additional information

Funding

Financial support was provided in part by the General Clinical Research Center at UTMB, Grant M01 RR 00073; the National Center for Research Resources, NIH, USPHS; the Agency for Healthcare Research and Quality grant R01-HS10613–02; and the clinical Research Education Program at UTMB, NIH K30-RR022276–08. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.